Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.
Dohlman TH, Singh RB, Amparo F, Carreno-Galeano T, Dastjerdi M, Coco G, Di Zazzo A, Shikari H, Saboo U, Sippel K, Ciralsky J, Yoo SH, Sticca M, Wakamatsu TH, Murthy S, Hamrah P, Jurkunas U, Ciolino JB, Saeed H, Gomes JAP, Perez VL, Yin J, Dana R. Dohlman TH, et al. Among authors: ciolino jb. Ophthalmol Sci. 2024 Feb 13;4(4):100492. doi: 10.1016/j.xops.2024.100492. eCollection 2024 Jul-Aug. Ophthalmol Sci. 2024. PMID: 38682029 Free PMC article.
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization.
Amparo F, Sadrai Z, Jin Y, Alfonso-Bartolozzi B, Wang H, Shikari H, Ciolino JB, Chodosh J, Jurkunas U, Schaumberg DA, Dana R. Amparo F, et al. Among authors: ciolino jb. Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):537-44. doi: 10.1167/iovs.12-11032. Invest Ophthalmol Vis Sci. 2013. PMID: 23233252 Free PMC article. Clinical Trial.
Retention of the Boston keratoprosthesis type 1: multicenter study results.
Ciolino JB, Belin MW, Todani A, Al-Arfaj K, Rudnisky CJ; Boston Keratoprosthesis Type 1 Study Group. Ciolino JB, et al. Ophthalmology. 2013 Jun;120(6):1195-200. doi: 10.1016/j.ophtha.2012.11.025. Epub 2013 Mar 15. Ophthalmology. 2013. PMID: 23499061 Free PMC article.
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities.
Dohlman CH, Cade F, Regatieri CV, Zhou C, Lei F, Crnej A, Harissi-Dagher M, Robert MC, Papaliodis GN, Chen D, Aquavella JV, Akpek EK, Aldave AJ, Sippel KC, DʼAmico DJ, Dohlman JG, Fagerholm P, Wang L, Shen LQ, González-Andrades M, Chodosh J, Kenyon KR, Foster CS, Pineda R, Melki S, Colby KA, Ciolino JB, Vavvas DG, Kinoshita S, Dana R, Paschalis EI. Dohlman CH, et al. Among authors: ciolino jb. Cornea. 2018 Feb;37(2):248-251. doi: 10.1097/ICO.0000000000001438. Cornea. 2018. PMID: 29135604 Free PMC article.
n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.
Dry Eye Assessment and Management Study Research Group; Asbell PA, Maguire MG, Pistilli M, Ying GS, Szczotka-Flynn LB, Hardten DR, Lin MC, Shtein RM. Dry Eye Assessment and Management Study Research Group, et al. N Engl J Med. 2018 May 3;378(18):1681-1690. doi: 10.1056/NEJMoa1709691. Epub 2018 Apr 13. N Engl J Med. 2018. PMID: 29652551 Free PMC article. Clinical Trial.
Oral guaifenesin for treatment of filamentary keratitis: A pilot study.
Coco G, Amparo F, Patel SP, Foulsham W, Carreno-Galeano JT, Stockslager SG, Ciolino JB, Yin J, Dana R. Coco G, et al. Among authors: ciolino jb. Ocul Surf. 2019 Jul;17(3):565-570. doi: 10.1016/j.jtos.2019.03.008. Epub 2019 Apr 1. Ocul Surf. 2019. PMID: 30946892
99 results